King Pharmaceuticals Showcases Data from Pain Pipeline of Medicines Designed To Deter Common Methods of Non-Therapeutic Use King Pharmaceuticals, Inc. announced that the Company is presenting safety and efficacy data for ACUROX and EMBEDA, two novel opioid analgesic formulations that are in development, at the 71st Annual Meeting of the College on Problems of Drug Dependence. King is also developing other pain medicines employing unique technology platforms designed to address risks associated with currently marketed opioids. [more...]
